Imaging Histone Deacetylase in the Heart

Imaging Histone Deacetylase in the Heart

Recruiting N/A Interventional Study
Heart Failure With Normal Ejection Fraction Left Ventricular Hypertrophy Aortic Valve Stenosis Diabetes
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
96 (estimated)
Sponsor
Massachusetts General Hospital · Other
Who this trial is looking for

This trial is looking for healthy volunteers and patients with diabetes or aortic stenosis. Participants will undergo special imaging to help understand heart conditions better.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am aged 18 to 85 years
  • I can provide informed consent
  • I have been diagnosed with diabetes
  • I have a recent echocardiogram without left ventricular hypertrophy
  • I have a recent echocardiogram showing aortic stenosis
  • I have no known history of medical disease
  • I have no history of cardiovascular disease

You may not be able to join if

  • I have a known contraindication to MRI

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The overall goal of this PET-MR imaging trial is to evaluate 11C-Martinostat, a histone deacetylase targeted radioligand, in patients with aortic stenosis, individuals with diabetes, and healthy volunteers.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Group 1: Healthy Volunteers (n = 30) * Healthy adults with no known history of medical disease * Age 18-85 years * No history cardiovascular disease * Ability to provide informed consent Group 2: Patients with Diabetes (n = 16) * Age 18-85 years * Diagnosis of diabetes * Echo…
Contacts

David E Sosnovik, MD

617-724-3407

dsosnovik@mgh.harvard.edu

CONTACT

Anne L Philip, MPH

617-726-0431

alphilip@mgh.harvard.edu

CONTACT